Medtronic (NYSE:MDT) said today it launched a new clinical trial evaluating the use of its ECG belt research system as a diagnostic tool for improving cardiac resynchronization therapy for heart failure patients. The Fridley, Minn.-based company said it has enrolled the first patients in the trial at Des Moines, Iowa’s Mercy Medical Center – West Lakes […]
Medtronic
Medtronic, GE Healthcare, Change Healthcare to share $33m in Israeli grants
Medtronic (NYSE:MDT), GE Healthcare (NYSE:GE) and Change Healthcare have received approximately $33.1 million (NIS 120 million) from the Israeli government to support expanding the companies R&D centers in the country, according to a CTech report. The grants are part of a six year, $264 million (NIS 922 million) program headed by the Israeli Ministry of Economy and […]
Medtronic wins expanded FDA nod for SelectSure pacing leads
Medtronic (NYSE:MDT) said today it won expanded FDA labeling for its SelectSecure MRI SureScan model 3830 cardiac pacing leads, now approved for His-bundle pacing. The Fridley, Minn.-based company said its bipolar, steroid-eluting SelectSecure leads are designed to be attached to a single or dual chamber pace maker and are now approved for pacing and sensing in […]
Thousands of Medtronic CRM devices need software upgrades
The FDA this week released notices from Medtronic (NYSE:MDT) warning of software issues with approximately 41,000 cardiac rhythm management devices. The warnings affect approximately 29,000 EnTrust and Escudo implantable cardioverter defibrillator devices and approximately 12,000 Percepta and Percepta Quad cardiac resynchronization therapy devices, according to urgent field notices sent out by the Fridley, Minn.-based company in […]
Medtronic wins FDA nod for thoracotomy-based HVAD procedure
Medtronic (NYSE:MDT) said today it won FDA approval for a thoracotomy alternative procedure with its HVAD left ventricular assist device, which it said is a less-invasive implantation approach. The Fridley, Minn.-based medtech giant touted the approval as the first for any commercially available LVAD in the US, and said that the clearance came based on data […]
Dynatronics taps ex-NinePoint CEO von Jako as chief exec | Personnel Moves – July 11, 2018
Dynatronics said late last month it tapped former NinePoint Medical CEO Christopher von Jako as its new chief executive officer and board member, succeeding Kelvyn Cullimore Jr. who will stay on the company’s board of directors. Prior to joining Dynatronics, von Jako acted as prez & CEO of NinePoint Medical. Before joining Nine Point, von Jako also […]
Medtronic touts one-year data from insulin pump study
Medtronic (NYSE:MDT) and UnitedHealthcare (NYSE:UNH) today touted first-year results from a 6,000-person analysis designed to compare hospital admission rates between people with diabetes using insulin pumps and people controlling their diabetes with multiple daily injections of insulin. The study included people using Medtronic’s MiniMed 630G system, as well as previous iterations of the medtech giant’s insulin pumps. Get […]
How can the medical device industry become more inclusive?
The medical technology industry has a gender diversity and inclusion problem – and these executives have a few ideas about how to solve it. At DeviceTalks Minnesota 2018, a panel of experts tackled a question that has long plagued the medical device industry: How can medtech become more inclusive? (For more insight into the medtech […]
Medtronic warns on connectivity issue with Guardian Connect app
Medtronic (NYSE:MDT) this month issued a letter to physicians warning them of a potential connectivity issue with the Guardian Connect mobile app. The medtech giant warned that people using the Guardian Connect system to keep track of their blood sugar levels should update to the latest version of the mobile app as soon as possible. Get […]
Medtronic launches outcomes-based reimbursement program for MiniMed 670G system
Medtronic (NYSE:MDT) today launched an outcomes-based reimbursement program for its MiniMed 670G automated insulin delivery system. As part of its ‘MiniMed 670G Performance Guarantee Program,’ the medtech giant will dole out flat-fee reimbursements of up to $25,000 per pump over four years for diabetes-related inpatient hospitalization and ER admissions. Get the full story at our sister […]
Medtronic wins $472m cardio device DoD contract
Medtronic (NYSE:MDT) won a $471.6 million contract with the US Department of Defense to provide it with cardiovascular products, according to a DoD release posted yesterday. The fixed-price with economic-price-adjustment, indefinite-deliver/indefinite-quantity contract is a sole-source acquisition deal for cardiovascular products, according to the release. The deal comes with a single year base contract and four one-year […]